Clinical trials
Recruiting Recurrence trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Daiichi Sankyo | 2 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| Calico Life Sciences LLC | 1 |
| Celgene | 1 |
| City of Hope Medical Center | 1 |
| Genmab | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 23 |
| Multiple Myeloma | 7 |
| Lymphoma, Follicular | 3 |
| Biliary Tract Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.